Back to results
US 12,616,921 B2Granted
Process for the deprotection of oligonucleotides
AssigneeHoffmann-La Roche Inc.
InventorsYong Rag Choi, Younggoo Kang, Sung Won Kim, Kyeong Eun Jung, Pascal Schmidt
Life of this patent
Estimating the term…
Abstract
The invention relates to a new process for the purification of oligonucleotides which comprises the removal of an acid labile 5′hydroxy protecting group at the 5′-O-oligonucleotide terminus of the oligonucleotide by means of an on-column de-protection with an acid.
Claims14
A method for purifying oligonucleotides comprising removing an acid labile 5′hydroxy protecting group at the 5′-O-oligonucleotide terminus of the oligonucleotide by way of an on-column de-protection with acetic acid, comprising the steps:
- a. passing a buffer solution comprising a phosphate salt and a polar aprotic solvent to an anion-exchange column as a first equilibration step;
- b. charging a diluted aqueous ammonia solution of a crude oligonucleotide onto the column;
- c. passing a buffer solution comprising a phosphate salt and a polar aprotic solvent to the column as a second equilibration step;
- d. washing the column with a buffer solution comprising a phosphate salt, a polar aprotic solvent and an alkali halide;
- e. passing a buffer solution comprising a phosphate salt and a polar aprotic solvent to the column as a third equilibration step;
- f. passing an acid solution to the column to remove an acid labile 5′hydroxy protecting group at the 5′-O-oligonucleotide terminus of the oligonucleotide;
- g. passing a buffer solution comprising a phosphate salt and a polar aprotic solvent to the column as a fourth equilibration step;
- h. eluting the de-protected oligonucleotide with a buffer solution comprising a phosphate salt, a polar aprotic solvent and an alkali halide.
5 more elements
Dependencies are inferred from the claim text.